Vistin Pharma ASA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was NOK 103.88 million compared to NOK 100.94 million a year ago. Net income was NOK 7.66 million compared to net loss of NOK 2.98 million a year ago.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
22 NOK | -1.35% | -6.78% | -5.58% |
Apr. 24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
1st Jan change | Capi. | |
---|---|---|
-5.58% | 91.36M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- VISTN Stock
- News Vistin Pharma ASA
- Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024